Andy Papas Ph.D.

Andy Papas, PhD, MBA has a diverse work experience in various leadership roles in regulatory affairs in the healthcare industry. Andy has served as the Vice President of Regulatory Affairs at NSF International - Health Sciences since 2013, where they provide strategic leadership and guidance on global regulatory affairs, quality, and drug development programs. Andy has also worked as the Director of Regulatory Affairs at the same company from 2011 to 2013. Prior to that, they worked as a Senior Principal Consultant at ANP Consulting, LLC in 2011. Andy has also held the position of Senior Director at Shire Human Genetic Therapies Inc from 2007 to 2010. Before that, they were the Director of the CMC RA group at Pfizer (formerly Wyeth) from 2001 to 2007, where they managed CMC regulatory strategy and life cycle management of a hemophilia franchise and led regulatory assessments of facility expansions and outsourcing scenarios. Andy also worked in CMC Regulatory Affairs at Sepracor from 2000 to 2001. Earlier in their career, they served as a Senior Manager at Polaroid from 1989 to 2000, where they managed analytical laboratories in research, development, and pilot plant. Andy began their career as a Scientist at the US FDA in 1978, where they conducted a broad range of activities including reviewing NDAs and ANDAs, conducting GMP inspections, and working on research programs.

Andy Papas, PhD, MBA has an extensive education history. Andy obtained their Bachelor of Arts degree in Chemistry from Boston University. Later on, they pursued further studies and earned a PhD in Chemistry from the University of Massachusetts Lowell. Furthermore, they attended the Questrom School of Business at Boston University to complete an MBA in International Business & Team Dynamics.